科文斯

As the drug development business of Laboratory Corporation of America Holdings (Labcorp) and the world’s most comprehensive drug development #CRO service company, we have helped pharmaceutical and biotech companies develop 100% of the top 50 prescription drugs in the marketplace today. Because of our broad experience and specialized expertise, we’re in a unique position to supply insights that go above and beyond testing. Together with our clients, we create solutions that transform potential into reality.

所属行业

研究服务

规模

超过 10,001 人

总部

Princeton，New Jersey

类型

上市公司

领域

Drug Development Services、Toxicology Services、Central Laboratory Services、Clinical Trial Management Services、Clinical Research、Phase I-IIa、Phase II-III、Preclinical Solutions、Cardiovascular、Oncology、Market Access、Rare Disease、Orphan Drugs、Biotech、Pharmaceuticals、Crop Protection、Clinical Trial Optimization、Market Access、Clinical Trials、Biologics、Cell and Gene Therapy、Pharmacovigilance、NASH、Infectious Diseases、Drug Testing、CRO、Immuno-Oncology、Commercialization、Pediatrics、Kidney Disease、Inflammation、Life Sciences、Bioassays、Bioanalysis、Biologics、Large Molecule和Small Molecule